Literature DB >> 2246029

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

S Julius1, A Mejia, K Jones, L Krause, N Schork, C van de Ven, E Johnson, J Petrin, M A Sekkarie, S E Kjeldsen.   

Abstract

During a survey of young subjects not receiving treatment for hypertension in Tecumseh, Michigan, clinic and self-monitored blood pressures taken at home (14 readings in 7 days) were obtained in 737 subjects (387 men, 350 women, average age 31.5 years). Hypertension in the clinic was diagnosed if the clinic blood pressure exceeded 140 mm Hg systolic or 90 mm Hg diastolic. In the absence of firm criteria for what constitutes hypertension at home, subjects whose average home blood pressure was in the upper decile of the whole population were considered to have hypertension at home. By these criteria, 7.1% of the whole population had "white coat" hypertension (i.e., high clinic but not elevated home readings). The prevalence of "sustained" hypertension (i.e., high readings in the clinic and at home) was 5.1%. Subjects with white coat and sustained borderline hypertension in Tecumseh were very similar. Both groups showed, at previous examinations (at ages 5, 8, 21, and 23 years), significantly higher blood pressure readings than the normotensive subjects. As young adults (average age 33.3 years), the parents of both hypertensive groups had significantly higher blood pressure readings than the parents of normotensive subjects. Both hypertensive groups had faster heart rates, higher systemic vascular resistance, and higher minimal forearm vascular resistance. Both hypertensive groups were more overweight, had higher plasma triglycerides, insulin, and insulin/glucose ratios than normotensive subjects. The white coat hypertensive group also had lower values of high density lipoprotein than the normotensive group. White coat hypertension is a frequent condition.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2246029     DOI: 10.1161/01.hyp.16.6.617

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Measurement and interpretation of blood pressure.

Authors:  C D Goonasekera; M J Dillon
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Reliability of patients measuring blood pressure at home: prospective observational study.

Authors:  A Nordmann; B Frach; T Walker; B Martina; E Battegay
Journal:  BMJ       Date:  1999-10-30

Review 3.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 4.  Prehypertension: a possible target for antihypertensive medication.

Authors:  S D Nesbitt; S Julius
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 5.  Importance of various methods of blood pressure measurement in clinical trials.

Authors:  P Palatini
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

6.  Ambulatory blood pressure measurement in general practice.

Authors:  J P Cox; K O'Malley; E O'Brien
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

Review 7.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

Review 8.  Ambulatory blood pressure monitoring: a guide for general practitioners.

Authors:  N Prasad; C Isles
Journal:  BMJ       Date:  1996-12-14

9.  Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey.

Authors:  M W Muscholl; H W Hense; U Bröckel; A Döring; G A Riegger; H Schunkert
Journal:  BMJ       Date:  1998-08-29

10.  Is There Any Correlation between Insulin Resistance and Nitrate Plasma Concentration in White Coat Hypertensive Patients?

Authors:  Leila Maria Marchi-Alves; Evelin Capellari Carnio
Journal:  Cardiol Res Pract       Date:  2009-08-24       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.